Grants and funders

We are grateful for the support of numerous funders who make the work of the Lochmüller Lab possible.

CRC-logo

Hanns holds the Canada Research Chair in Neuromuscular Genomics and Health and our lab’s work is supported by funding from the Canada Research Chairs program.

leaf-cihr-colour-portrait-en
CFI_CMYK

The Canada Foundation for Innovation (CFI) supports equipment in our lab as part of the CRC award.

Canada First Research fund
New frontiers in research fund
255px-Flag_of_Europe

The New Frontiers in Research Fund and European Commission supports the Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular diseases by exploiting SIMilarities in clinical and molecular PATHology (SIMPATHIC).

EJPRD

Funding from the European Joint Programme for Rare Diseases (EJP-RD) supports the PROMOT network: Performing a Rare Disease-Oriented Master Observational Trial to decipher complexity and optimize trial readiness (with Canadian funding contributed by the CIHR), and ProdGNE: Novel therapeutic approaches to target GNE Myopathy (with Canadian funding contributed by the CIHR). 

MDClogo_colour

We are supported by Muscular Dystrophy Canada with a Network Grant in Muscular Dystrophy for NMD4C, a neuromuscular network for Canada (jointly funded by CIHR).

University of Ottawa logo

Stephen Holland is the recipient of a Scholarship in Translational Research (STaR) Award from the Dr. Eric Poulin Centre for Neuromuscular Disease (CNMD) in partnership with the University of Ottawa Brain and Mind Research Institute (uOBMRI). This award supports Stephen’s research over 2024-2025. 

Kaela O'Connor is the recipient of a Queen Elizabeth II scholarship award, which will allow her to continue her research for the 2023-2024 academic year. 

support

Read next...

Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic Syndrome (CMS) is the first...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers critical genetic mutations linked to...
New leadership for the University of Ottawa Centre for Neuromuscular Disease, Drs Mireille Khacho and Hanns Lochmuller.

Drs Hanns Lochmüller and Mireille Khacho New Leaders of University of Ottawa Eric Poulin Centre for Neuromuscular Disease

We are delighted to share exciting news from the uOttawa Brain and Mind Research Institute (uOBMRI)! Drs. Hanns Lochmüller and Mireille Khacho have been appointed as the new leaders for...
Dr Lola Lessard and Kelly Ho receive prestigious research poster awards

Lab Members Receive Research Poster Awards at National and International Conferences

Kelly Ho Receives Poster Award at World Muscle Society Congress Congratulations to PhD researcher Kelly Ho, whose poster presentation "Investigating muscle specific kinase antibody treatment for Agrn and ColQ Congenital...
Clinical trial updates in FSHD

FSHD Clinical Trial Updates

Two clinical trial opportunities in FSHD at The Ottawa NeuroMuscular Centre now recruiting, FSHD community receive negative topline results from phase 3 losmapimod (REACH) trial. Last week the Facioscapulohumeral muscular...
Lessard-funding-DM1_1200x900 (1)

Dr. Lola Lessard Receives Postdoctoral Fellowship to study AMPK signaling in DM1

We are excited to share that  Dr. Lola Lessard has been awarded a one-year postdoctoral research fellowship from AFM-Téléthon to study AMP-activated protein kinase (AMPK) signaling in Type I Myotonic...